Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
One-Compartment Model: IV Infusion01:09

One-Compartment Model: IV Infusion

Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
Two-Compartment Open Model: IV Infusion01:15

Two-Compartment Open Model: IV Infusion

A two-compartment model is a vital tool in pharmacokinetics, providing an essential understanding of drug behavior, especially for those administered via zero-order intravenous infusion. This model outlines two compartments: the central compartment, where elimination occurs, and the peripheral compartment.
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
IV Infusion to Oral Dosing: Conversion Methods01:28

IV Infusion to Oral Dosing: Conversion Methods

The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rare Plaque Rupture Within a Myocardial Bridge Presenting as Acute Anterior STEMI.

JACC. Case reports·2026
Same author

Dysplasia detection using high-definition scopes with dye vs virtual chromoendoscopy in IBD: A meta-analysis of randomized clinical trials.

Inflammatory bowel diseases·2026
Same author

Prevalence and sex differences in endoscopy-related injuries: comprehensive systematic review and meta-analysis.

iGIE : innovation, investigation and insights·2026
Same author

Frequency of computed tomography scans in Crohn's disease patients in the emergency department.

Inflammatory bowel diseases·2026
Same author

Pneumococcal Vaccine Is Associated with Improved Outcomes in Inflammatory Bowel Disease: Insights from a Propensity-Matched Study in the United States.

Digestive diseases and sciences·2026
Same author

Medical management of inflammatory bowel diseases.

BMJ (Clinical research ed.)·2025

Related Experiment Video

Updated: Jul 18, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

Infusion services in the gastroenterology practice.

Bret Ancowitz1, Samir A Shah

  • 1Division of Gastroenterology and Hepatology, Brown University Medical School, Providence, RI, USA.

Gastrointestinal Endoscopy Clinics of North America
|November 14, 2006
PubMed
Summary

Gastroenterology practices can enhance patient care and revenue by offering infusion therapies. Biologic agents for inflammatory bowel disease management represent a key economic opportunity.

More Related Videos

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices
04:09

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices

Published on: June 13, 2025

Construction and Implantation of a Microinfusion System for Sustained Delivery of Neuroactive Agents.
12:17

Construction and Implantation of a Microinfusion System for Sustained Delivery of Neuroactive Agents.

Published on: March 17, 2008

Related Experiment Videos

Last Updated: Jul 18, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices
04:09

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices

Published on: June 13, 2025

Construction and Implantation of a Microinfusion System for Sustained Delivery of Neuroactive Agents.
12:17

Construction and Implantation of a Microinfusion System for Sustained Delivery of Neuroactive Agents.

Published on: March 17, 2008

Area of Science:

  • Gastroenterology
  • Pharmacology
  • Health Services Management

Background:

  • Gastroenterology practices seek service diversification for patient benefit and revenue generation.
  • Infusion therapies offer a valuable service, with biologic agents for inflammatory bowel disease (IBD) management being a key economic driver.
  • While rehydration fluids and iron infusions have roles, biologic infusions are highlighted for practice profitability.

Purpose of the Study:

  • To explore the economic and clinical benefits of offering infusion therapies in gastroenterology practices.
  • To emphasize the significance of biologic agent infusions in the management of inflammatory bowel disease (IBD).
  • To position infusion services as a strategic growth opportunity for gastroenterology practices.

Main Methods:

  • Review of current infusion therapy services relevant to gastroenterology.
  • Analysis of the economic impact of different infusion types on practice revenue.
  • Focus on biologic agents as a primary area for infusion therapy expansion.

Main Results:

  • Infusion therapies present a significant opportunity for gastroenterology practices to increase revenue.
  • Biologic agent infusions are identified as the most economically beneficial infusion therapy for practices.
  • The role of biologic agents in IBD management is expected to remain crucial for the foreseeable future.

Conclusions:

  • Gastroenterology practices should consider integrating infusion therapies, particularly biologic agents.
  • Implementing infusion services can enhance patient care and create a substantial new revenue stream.
  • Biologic infusions are vital for the long-term management of inflammatory bowel disease and practice growth.